NSG Mice Lacking Apoe : An Immunodeficient Mouse Model of Atherosclerosis
The FASEB Journal · 31.10.2026 · 40 (20)
DOI: 10.1096/fj.202603399r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 21.10.2026. Verfasst von Hannah R Megathlin und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Jackson Laboratory, Bar Harbor, Maine, USA. Hauptthemen laut MEDLINE: Atherosclerosis, Disease Models, Animal, Apolipoproteins E. Die Arbeit nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIGMS NIH HHS, HHS | NIH | National Institute of General Medical Sciences (NIGMS).
Abstract (Originalsprache)
Murine research on atherosclerosis has been conducted largely on the C57BL/6 (B6) strain background, and most commonly, the B6.129P2‐ Apoe tm1Unc /J (B6‐ApoE KO ) strain. The use of the B6 background strain limits translatability for immunotherapy development due to inherent species differences between human and mouse immune systems. A proposed solution to this limitation is a humanized mouse model of atherosclerosis that would support the engraftment of human lymphoid and myeloid cell populations. The development of such a model has been hindered by the lack of a mouse strain that both develops atherosclerosis and supports human immune cell engraftment. In this paper, we report on a NOD.Cg‐ Prkdc scid Il2rg tm1Wjl /Sz (NSG) immunodeficient mouse strain that has a 383 bp deletion in the Apoe gene which prevents ApoE protein expression. When maintained on a high fat diet, NSG‐ApoE KO mice develop hypercholesteremia and atherosclerosis at levels similar to B6‐ApoE KO mice. While atherosclerosis in B6‐ApoE KO mice has been widely studied in many laboratories under multiple conditions, our initial study of disease development in NSG‐ApoE KO mice was limited and future comparative studies with B6‐ApoE KO mice are necessary. NSG‐ApoE KO mice concomitantly support human cell engraftment while developing atherosclerosis, thereby making them useful to study human‐specific immune aspects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Jackson Laboratory, Bar Harbor, Maine, USA.
- Graduate School of Biomedical Sciences and Engineering, University of Maine, Orono, Maine, USA.
- Program in Molecular Medicine, Diabetes Center of Excellence, UMass Chan Medical School, Worcester, Massachusetts, USA.
ORCID-Profile: Hannah R Megathlin, Lisa Burzenski, David A Coleman, Blaze Albert, Michelle L Farley, Michael A Brehm, Dale L Greiner, Leonard D Shultz
Förderung
- NIDDK NIH HHS
- NIGMS NIH HHS
- HHS | NIH | National Institute of General Medical Sciences (NIGMS)
- HHS | NIH | NIDDK | Division of Diabetes, Endocrinology, and Metabolic Diseases (DEM)
- Jackson Laboratory (JAX)
- Breakthrough T1D (JDF)
- National Institute of General Medical Sciences
Zitieren
APA
Megathlin, H. R., Burzenski, L., Coleman, D. A., Albert, B., Farley, M. L., Brehm, M. A., Greiner, D. L., & Shultz, L. D. (2026). NSG Mice Lacking Apoe : An Immunodeficient Mouse Model of Atherosclerosis. The FASEB Journal, 40(20). https://doi.org/10.1096/fj.202603399r
Vancouver
Megathlin HR, Burzenski L, Coleman DA, Albert B, Farley ML, Brehm MA, et al. NSG Mice Lacking Apoe : An Immunodeficient Mouse Model of Atherosclerosis. The FASEB Journal. 2026;40(20). doi:10.1096/fj.202603399r
BibTeX
@article{Megathlin2026,
author = {Megathlin, Hannah R and Burzenski, Lisa and Coleman, David A and Albert, Blaze and Farley, Michelle L and Brehm, Michael A and Greiner, Dale L and Shultz, Leonard D},
title = {NSG Mice Lacking Apoe : An Immunodeficient Mouse Model of Atherosclerosis},
journal = {The FASEB Journal},
year = {2026},
volume = {40},
number = {20},
doi = {10.1096/fj.202603399r}
}
EUVIMED